Loading…

O-017 A Phase I/II trial of erlotinib (ERLO) in higher-risk MDS after azacitidine (AZA) failure

Saved in:

Bibliographic Details
Published in:	Leukemia research 2013-05, Vol.37, p.S16-S17
Main Authors:	Thepot, S, Boehrer, S, Prebet, T, Beyne-Rauzy, O, Wattel, E, Delaunay, J, Raffoux, E, Schmidt, A.L, Wickenhauser, S, Dreyfus, F, Fenaux, P, Adès, L
Format:	Article
Language:	English
Subjects:	Hematology, Oncology and Palliative Medicine
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!